Company Analysis

Sonoma Pharmaceuticals, Inc. (SNOA)

Nasdaq: SNOA · Surgical & Medical Instruments & Apparatus · Boulder, CO · filing with the SEC since 2002
Grade4.2
◀ Past 2.2● Present 4.4▶ Future 6.0
1 est.

Who runs Sonoma Pharmaceuticals, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Trombly Amy Moss
Chief Executive Officer. First filing Oct 2019, latest Jul 9, 2026, 0 filings in all.
Officers reporting now
3
of 7 people with a filing in the last fifteen months
Directors reporting now
4
17 people on the record since 2007
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Trombly Amy MossChief Executive OfficerOct 2019Jul 9, 2026none
Dvonch Jerome JChief Financial OfficerSep 2020Jul 9, 2026none
Dal Poggetto JohnControllerOct 2019Jul 9, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Jacoby VanessadirectorFeb 2026Jul 9, 2026none
Mclaughlin JohndirectorMar 2013Jul 9, 2026none
Weigerstorfer PhilippedirectorSep 2018Jul 9, 2026none
Birnbaum Jay EdirectorApr 2007Jan 2, 2026none
Earlier names on the record10, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton SNOA · research, not advice